Y Nakanishi Selected Research

Y Nakanishi Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 01/2000
13	Carcinoma (Carcinomatosis) 03/2011 - 08/2000
10	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2000
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2000
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013 - 02/2000
6	Lymphatic Metastasis 07/2007 - 01/2000
5	Adenocarcinoma 10/2014 - 01/2000
5	Stomach Neoplasms (Stomach Cancer) 10/2006 - 01/2001
5	Neoplasm Metastasis (Metastasis) 12/2001 - 01/2000
3	Infections 01/2017 - 02/2004
3	Colorectal Neoplasms (Colorectal Cancer) 06/2012 - 12/2001
3	Fibrosis (Cirrhosis) 12/2007 - 01/2004
3	Carcinogenesis 10/2006 - 01/2001
2	Mouth Neoplasms (Oral Cancer) 09/2021 - 01/2001
2	Colitis 01/2018 - 01/2015
2	Adenocarcinoma of Lung 01/2017 - 01/2017
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2014 - 07/2000
2	Breast Neoplasms (Breast Cancer) 05/2007 - 01/2000
2	Inflammation (Inflammations) 12/2004 - 03/2004
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2004 - 01/2004
2	Necrosis 03/2004 - 08/2001
2	Ischemia 07/2001 - 03/2001
1	Human Influenza (Influenza) 10/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Meningeal Carcinomatosis 01/2018
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2017
1	Cross Infection (Nosocomial Infection) 11/2017
1	Disease Progression 01/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017
1	Kidney Neoplasms (Kidney Cancer) 01/2017
1	Pleurisy (Pleuritis) 01/2017
1	Exanthema (Rash) 04/2015
1	Thymoma (Thymic Carcinoma) 02/2015
1	Thymus Neoplasms (Thymus Neoplasm) 02/2015
1	Cubital Tunnel Syndrome 01/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2000
5	Messenger RNA (mRNA)IBA 06/2012 - 01/2001
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 08/2001
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2000
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2015 - 03/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2007 - 04/2000
4	Indicators and Reagents (Reagents)IBA 03/2003 - 01/2000
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2001
3	Carboplatin (JM8)FDA LinkGeneric 02/2015 - 11/2008
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2014 - 02/2000
3	Retinaldehyde (Retinal)IBA 09/2008 - 08/2006
3	Cadherins (E-Cadherin)IBA 05/2007 - 03/2003
3	CollagenIBA 01/2004 - 07/2000
3	Fas Ligand Protein (Fas Ligand)IBA 07/2001 - 03/2000
3	Monoclonal AntibodiesIBA 07/2001 - 01/2000
2	NivolumabIBA 12/2017 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 04/2015 - 10/2014
2	ProdrugsIBA 02/2008 - 05/2000
2	EnzymesIBA 02/2008 - 01/2000
2	Caspase 3 (Caspase-3)IBA 07/2007 - 03/2003
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2007 - 04/2000
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2004 - 08/2001
2	Antineoplastic Agents (Antineoplastics)IBA 03/2003 - 02/2000
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2001 - 04/2000
2	AntigensIBA 07/2001 - 02/2001
2	Etoposide (VP 16)FDA LinkGeneric 07/2001 - 06/2001
2	Concanavalin AIBA 03/2001 - 01/2001
2	Cisplatin (Platino)FDA LinkGeneric 10/2000 - 03/2000
1	BilirubinIBA 01/2022
1	AlbuminsIBA 01/2022
1	VaccinesIBA 10/2019
1	Enterotoxins (Enterotoxin)IBA 10/2019
1	InterferonsIBA 01/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2018
1	STAT1 Transcription FactorIBA 01/2018
1	pembrolizumabIBA 01/2018
1	AfatinibIBA 01/2017
1	Urethane (Ethyl Carbamate)IBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Viral DNAIBA 01/2017
1	Surface-Active Agents (Surfactants)IBA 01/2017
1	LipidsIBA 04/2015
1	AnthracyclinesIBA 02/2015
1	CytokinesIBA 01/2015
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2015
1	Vancomycin FDA LinkGeneric 01/2015
1	Dextrans (Dextran)FDA Link 01/2015
1	Immune Checkpoint InhibitorsIBA 10/2014
1	amrubicinIBA 02/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2014
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 05/2013
1	ChitinasesIBA 06/2012
1	Blood Proteins (Serum Proteins)IBA 06/2012
1	PhosphotyrosineIBA 03/2011
1	src-Family KinasesIBA 03/2011

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2000
8	Drug Therapy (Chemotherapy) 01/2022 - 02/2000
5	Radiotherapy 01/2010 - 01/2000
5	Lymph Node Excision (Lymph Node Dissection) 12/2001 - 01/2000
5	Esophagectomy 12/2001 - 08/2000
1	Immunotherapy 01/2022
1	Perioperative Period 09/2021
1	Bathroom Equipment 11/2017
1	Decompression 01/2014